Adam Good is the Founder & Principal of Archentis Partners, a life sciences advisory firm focused on development strategy and program leadership.  The firm partners with biotechnology and pharmaceutical companies at pivotal stages of growth—translating scientific innovation into structured, capital-efficient development pathways.

Adam brings more than 17 years of experience across biotech, pharmaceutical, and venture-backed environments. His work spans small molecules, biologics, oncology, antisense therapies, and rare disease platforms across a broad range of complex indications.

He operates at the intersection of strategy and delivery—supporting executive teams in defining development roadmaps, establishing governance architecture, portfolio prioritization, and aligning organizations around clear value inflection points. His approach combines disciplined planning with practical execution leadership.

Archentis was established to provide advisory support with defining development roadmaps, building governance structures, portfolio prioritization, and aligning cross-functional organizations around measurable value inflection points. The firm is built to expand alongside client needs, supporting increasingly complex portfolios and organizational maturity.